Office of Biotechnology Activities, Office of Science Policy, Office of the Director; Notice of Closed Meeting, 60744 [06-8706]

Download as PDF 60744 Federal Register / Vol. 71, No. 199 / Monday, October 16, 2006 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of Biotechnology Activities, Office of Science Policy, Office of the Director; Notice of Closed Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Science Advisory Board for Biosecurity (NSABB). Under authority 42 U.S.C. 217a, Section 222 of the Public Health Service Act, as amended, the Department of Health and Human Services established NSABB to provide advice, guidance and leadership regarding Federal oversight of dual-use research, defined as biological research with legitimate scientific purposes that could be misused to pose a biological threat to public health and/or national security. The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(1), Title 5 U.S.C., as amended because matters sensitive to the interest of national security will be presented. Name of Committee: National Science Advisory Board for Biosecurity. Date: October 26, 2006. Time: 12 p.m. to 5 p.m. Agenda: Representatives from the Intelligence Community will present a classified session on the current counterterrorism and counterproliferation threats to the U.S. Place: At a predetermined location in Virginia. Contact Person: Laurie Lewallen, NSABB Program Assistant, NIH Office of Biotechnology Activities, 6705 Rockledge Drive, Bethesda, Maryland 20892, (301) 496– 9838. Dated: October 5, 2006. Linda Payne, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–8706 Filed 10–13–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health jlentini on PROD1PC65 with NOTICES Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the VerDate Aug<31>2005 16:16 Oct 13, 2006 Jkt 211001 provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Genes, Genomes, and Genetics Integrated Review Group, Genetic Variation and Evolution Study Section. Date: October 12–13, 2006. Time: 8:30 a.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: The River Inn, 924 25th Street, NW., Washington, DC 20037. Contact Person: David J. Remondini, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2210, MSC 7890, Bethesda, MD 20892. 301–435– 1038. remondid@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, Fungal Pathogens. Date: October 13, 2006. Time: 1:30 p.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Fouad A. El-Zaatari, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3206, MSC 7808, Bethesda, MD 20814–9692. (301) 435–1149. etzaataf@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Hematology Integrated Review Group, Hemostasis and Thrombosis Study Section. Date: October 19, 2006 Time: 8:30 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Holiday Inn Georgetown, 2901 Wisconsin Avenue, Washington, DC 20007. Contact Person: Chhanda L. Ganguly, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4118, MSC 7802, Bethesda, MD 20892. (301) 435– 1739. gangulyc@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, Incidence of Hemochromatosis/Iron Overload and Associated Disorders. Date: October 19, 2006. PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 Time: 2 p.m to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: Holiday Inn Chevy Chase, 5520 Wisconsin Avenue, Chevy Chase, MD 20815. Contact Person: Christopher Sempos, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3146, MSC 7770, Bethesda, MD 20892. (301) 451– 1329. semposch@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, Developmental Disabilities, Communication and Science Education. Date: October 23, 2006. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: The Drake Hotel, 140 E. Walton Place, Chicago, IL 60611. Contact Person: Thomas A. Tatham, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3178, MSC 7848, Bethesda, MD 20892. (301) 594– 6836. tathamt@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, Oral Complications of Cancer Therapies. Date: October 31, 2006–November 1, 2006. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Eva Petrakova, PhD, MPH, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6158, MSC 7804, Bethesda, MD 20892. 301–435– 1716. petrakoe@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Nanomicroscopy in Heart Failure. Date: October 31, 2006. Time: 2 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Bukhtiar H. Shah, DVM, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4095J, MSC 7822, Bethesda, MD 20892. 301–435– 1233. shahb@csr.nih.gov. Name of Committee: AIDS and Related Research Integrated Review Group, AIDS Clinical Studies and Epidemiology Study Section. Date: November 1–2, 2006. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\16OCN1.SGM 16OCN1

Agencies

[Federal Register Volume 71, Number 199 (Monday, October 16, 2006)]
[Notices]
[Page 60744]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-8706]



[[Page 60744]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of Biotechnology Activities, Office of Science Policy, 
Office of the Director; Notice of Closed Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the National Science Advisory Board for Biosecurity (NSABB).
    Under authority 42 U.S.C. 217a, Section 222 of the Public Health 
Service Act, as amended, the Department of Health and Human Services 
established NSABB to provide advice, guidance and leadership regarding 
Federal oversight of dual-use research, defined as biological research 
with legitimate scientific purposes that could be misused to pose a 
biological threat to public health and/or national security.
    The meeting will be closed to the public in accordance with 
provisions set forth in section 552b(c)(1), Title 5 U.S.C., as amended 
because matters sensitive to the interest of national security will be 
presented.

    Name of Committee: National Science Advisory Board for 
Biosecurity.
    Date: October 26, 2006.
    Time: 12 p.m. to 5 p.m.
    Agenda: Representatives from the Intelligence Community will 
present a classified session on the current counterterrorism and 
counterproliferation threats to the U.S.
    Place: At a predetermined location in Virginia.
    Contact Person: Laurie Lewallen, NSABB Program Assistant, NIH 
Office of Biotechnology Activities, 6705 Rockledge Drive, Bethesda, 
Maryland 20892, (301) 496-9838.

    Dated: October 5, 2006.
Linda Payne,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-8706 Filed 10-13-06; 8:45 am]
BILLING CODE 4140-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.